甲状腺功能异常的诊断:参考区间应服务患者而非数值
本文讨论甲状腺功能诊断中参考区间的局限性,包括甲状腺参数的暂时性变化、个体间与个体内差异、年龄相关差异及种族差异。统计学计算的甲状腺分析物分布不一定与具有预测健康结局价值的区间或切点一致。基于当前临床试验数据,尚不清楚哪些轻度促甲状腺激素升高的个体能从左甲状腺素治疗中获益。
要点
- 甲状腺功能诊断需结合完整临床情况个体化评估,不能仅依赖参考区间。
- 统计学计算的参考分布不一定与预测健康结局的切点一致。
- 轻度TSH升高者从左甲状腺素治疗中获益的人群尚不明确。
核心结论
- 甲状腺功能异常的诊断不能仅凭数值参考区间,需结合患者完整临床情况个体化评估。
- 统计学计算的甲状腺分析物分布不一定与对健康结局有预测价值的区间或切点一致。
研究设计与样本
- 本文为综述,讨论甲状腺功能诊断中参考区间应用的局限性与临床评估策略。
主要发现
- 甲状腺功能是否正常常不明确,涉及甲状腺参数暂时性变化、个体间与个体内差异、年龄相关差异及种族差异。
- 基于当前临床试验数据,尚不清楚哪些轻度促甲状腺激素升高的个体能从左甲状腺素治疗中获益。
- 仅少数促甲状腺激素超过10 mIU/L的患者在随机化研究中被研究过。
- 即使对甲状腺功能异常启动治疗,并非所有治疗个体维持在期望的治疗目标,因此仍可能处于风险中。
临床怎么用
- 每位患者的甲状腺功能需结合完整临床情况个体化评估。
- 监测需保持警惕,并持续重新评估治疗目标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Although assigning a diagnosis of thyroid dysfunction appears quite simple, this is often not the case. Issues that make it unclear whether thyroid function is normal include transient changes in thyroid parameters, inter-individual and intra-individual differences in thyroid parameters, age-related differences, and ethnic variations. In addition, a statistically calculated distribution of thyroid analytes does not necessarily coincide with intervals or cutoffs that have predictive value for beneficial or adverse health outcomes. Based on current clincial trial data, it is unclear which individuals with mild thyroid-stimulating hormone elevations will benefit from levothyroxine treatment. For example, only a small number of patients with thyroid-stimulating hormone values of more than 10 mIU/L have been studied in a randomised manner. Even if therapy is initiated for abnormal thyroid function, not all treated individuals are maintained at the desired treatment target, and therefore might still be at risk. The consequence of this is that each patient's thyroid function needs to be assessed on an individual basis with the entire clinical picture in mind. Monitoring also needs to be vigilant, and the targets for treatment reassessed continually.
引用
- Jonklaas J, Razvi S. Reference intervals in the diagnosis of thyroid dysfunction: treating patients not numbers. Lancet Diabetes Endocrinol. 2019. PMID: 30797750. doi:10.1016/S2213-8587(18)30371-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。